<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03210519</url>
  </required_header>
  <id_info>
    <org_study_id>CS15036</org_study_id>
    <nct_id>NCT03210519</nct_id>
  </id_info>
  <brief_title>To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Eleutherococcus Senticosus for Anti-inflammation and Improvement of Erythropoietin Hyporesponsiveness in Subjects Under Renal Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled, parallel comparison trial to evaluate
      the efficacy and safety of Eleutherococcus Senticosus taken orally by patients under regular
      dialysis. Eligible subjects with written consent were randomized into one of the two groups:
      A. Acanthopanax senticosus (30mg/vial); B. Placebo. After 2-4 weeks of run-in period, the
      study subjects were asked to take the investigational products orally for 90 days in order to
      evaluate the effects of oral Eleutherococcus Senticosus liquid on the markers of
      inflammation, anemia, and safety, and to compare the efficacy among oral Acanthopanax
      senticosus and placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 9, 2015</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Erythropoietin (EPO)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin (Hb)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Red Blood Cell (RBC)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematocrit (Hct)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Corpuscular Hemoglobin Concentration (MCHC)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Corpuscular Volume (MCV)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Corpuscular Hemoglobin (MCH)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intact Parathyroid Hormone (iPTH)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor Necrosis Factor - Alpha (TNF-alpha)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin 6 (IL-6)</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>value at 3 months minus value at baseline reported</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Renal Dialysis</condition>
  <arm_group>
    <arm_group_label>Eleutherococcus senticosus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Eleutherococcus senticosus</intervention_name>
    <description>taken orally once/day for 90 days</description>
    <arm_group_label>Eleutherococcus senticosus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>taken orally once/day for 90 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Under regular dialysis for at least 3 months

          -  Hemoglobin (Hb) &lt;11 g/L after regular Erythropoietin (EPO) treatment

          -  Subjects with written informed consent form

        Exclusion Criteria:

          -  Use of steroid or high dose of antiplatelet drug (e.g. Aspirin &gt;300mg) within one
             month

          -  Had surgery, myocardial infarction, or tumor within 12 weeks

          -  Currently use of antibiotic treatment for acute infection

          -  Pregnant women

          -  Reticulocyte&gt;40 x 10^9

          -  Anemia (ferritin &lt;100ng/mL and Transferrin Saturation (TSAT) &lt;20%)

          -  Urea reduction ratio &lt;65% or single pool Kt/V &lt; 1.0 (hemodialysis patients) or total
             weekly Kt/V&lt;1.7 (peritoneal dialysis patients)

          -  Sudden change of eating habit within one month

          -  Expected life less than six months or with unstable medical conditions

          -  Known history of allergic reaction to the investigational products

          -  With acute diseases and judged by the investigator to be ineligible to participate

          -  Received melatonin, androgen therapy or blood transfusion within two months

          -  Received any trial medications within 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nae-Cherng Yang, Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chun Shan Medical University</affiliation>
  </overall_official>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 3, 2017</study_first_submitted>
  <study_first_submitted_qc>July 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <results_first_submitted>April 13, 2020</results_first_submitted>
  <results_first_submitted_qc>April 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 6, 2020</results_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>Nae-Cherng Yang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 5, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT03210519/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Eleutherococcus Senticosus</title>
          <description>Participants first received screening tests for up to 30 days. Eligible subjects were then given the investigational products (Acanthopanax senticosus-mono formula 30mg/vial and Fructus Ziziphi Jujube concentrated juice15ml/vial) to be taken orally once/day for 90 days. Patients with hyperacidity and gastroesophageal reflux were recommended to take it after meals.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Participants first received screening tests for up to 30 days. Eligible subjects were then given the investigational products (Fructus Ziziphi Jujube concentrated juice15ml/vial) to be taken orally once/day for 90 days. Patients with hyperacidity and gastroesophageal reflux were recommended to take it after meals.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Eleutherococcus Senticosus</title>
          <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="13.1"/>
                    <measurement group_id="B2" value="55.8" spread="11.3"/>
                    <measurement group_id="B3" value="60.1" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Erythropoietin (EPO)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Erythropoietin (EPO)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>u/mth</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6000.0" spread="5916.5"/>
                    <measurement group_id="O2" value="-1714.3" spread="6264.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hemoglobin (Hb)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin (Hb)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>gm/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.1"/>
                    <measurement group_id="O2" value="-0.1" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Red Blood Cell (RBC)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Red Blood Cell (RBC)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>10^4 cells/ul</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.1" spread="35.6"/>
                    <measurement group_id="O2" value="-7.8" spread="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematocrit (Hct)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Hematocrit (Hct)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>vol% RBC in blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="3.2"/>
                    <measurement group_id="O2" value="-0.3" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Corpuscular Hemoglobin Concentration (MCHC)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Corpuscular Hemoglobin Concentration (MCHC)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>g/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="0.3"/>
                    <measurement group_id="O2" value="-0.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Corpuscular Volume (MCV)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Corpuscular Volume (MCV)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>fl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="3.0"/>
                    <measurement group_id="O2" value="1.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Corpuscular Hemoglobin (MCH)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Corpuscular Hemoglobin (MCH)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>Pg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="1.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intact Parathyroid Hormone (iPTH)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Intact Parathyroid Hormone (iPTH)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.6" spread="240.5"/>
                    <measurement group_id="O2" value="-97.9" spread="149.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tumor Necrosis Factor - Alpha (TNF-alpha)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Tumor Necrosis Factor - Alpha (TNF-alpha)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-17.2" spread="16.1"/>
                    <measurement group_id="O2" value="-14.9" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin 6 (IL-6)</title>
        <description>value at 3 months minus value at baseline reported</description>
        <time_frame>baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Eleutherococcus Senticosus</title>
            <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin 6 (IL-6)</title>
          <description>value at 3 months minus value at baseline reported</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-20.3" spread="28.7"/>
                    <measurement group_id="O2" value="-0.7" spread="41.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 and 3 months</time_frame>
      <desc>Vital signs and patients' self-evaluation of their tolerance and physical improvement was assessed by a structured patient questionnaire administered at months 1 and 3</desc>
      <group_list>
        <group group_id="E1">
          <title>Eleutherococcus Senticosus</title>
          <description>Acanthopanax senticosus-mono formula (30mg/vial) and Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Fructus Ziziphi Jujube concentrated juice15ml/vial</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Subjects complained uncomfortable</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Nae-Cherng Yang</name_or_title>
      <organization>Department of Nutrition, Chung Shan Medical University</organization>
      <phone>886-0936810214</phone>
      <email>naeman@csmu.edu.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

